酶固定纳米载体在骨质疏松症中的新兴作用:进展和挑战
Nie Tang1, Yubing Huang2, Ying Zhu1
1Department of Endocrinology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, People's Republic of China.
International journal of nanomedicine
|December 10, 2025
概括
纳米技术为骨质疏松症 (OP) 治疗提供了新的希望. 酶固定纳米载体增强药物输送到骨,促进再生和减少副作用,以更好地治疗骨质疏松症.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 整形外科 整形外科 整形外科
背景情况:
- 骨质疏松症 (OP) 是一种普遍存在的骨疾病,其特点是骨质较低,骨折风险增加.
- 传统的OP疗法面临着诸如全身副作用和向不良等局限性.
研究的目的:
- 审查酶固定纳米载体的开发,以加强骨质疏松症治疗.
- 突出这些系统在刺激骨形成和抑制骨再吸收方面的潜力.
主要方法:
- 对OP中纳米技术应用的当前文献的综述.
- 专注于酶固定化策略 (例如,性酸盐酶,超氧化脱酶,甲素K抑制剂).
- 纳米载体类型 (聚合纳米粒子,脂质体) 和它们的机制的解释.
主要成果:
- 酶固定增强治疗剂在目标部位的稳定性和活性.
- 纳米载体改善药物输送,生物可用性,并释放动力学,以获得持续的治疗效果.
- 在体外和体内研究表明,在刺激骨质细胞功能和抑制骨质细胞活性方面具有潜力.
结论:
- 酶固定纳米载体代表了针对性骨质疏松症治疗的有希望的平台.
- 需要进一步的研究来改善这些纳米载体系统的向性和促进临床转化.
更多相关视频
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
9.7K
08:28A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling
Published on: May 21, 2020
7.2K
相关概念视频
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Role of Vitamins in Maintaining Bone Health
5.0K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.0K
Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
